RHÖN-KLINIKUM Aktiengesellschaft (RKAGY)
USD 6.05
(0.0%)
USD 6.05
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 499.09 Million EUR | 10.05% |
| 2022 | 453.51 Million EUR | 2.88% |
| 2021 | 440.81 Million EUR | 0.31% |
| 2020 | 439.44 Million EUR | -1.49% |
| 2019 | 446.11 Million EUR | 3.73% |
| 2018 | 430.06 Million EUR | 24.25% |
| 2017 | 346.14 Million EUR | 0.96% |
| 2016 | 342.86 Million EUR | -34.79% |
| 2015 | 525.77 Million EUR | -5.33% |
| 2014 | 555.38 Million EUR | -61.2% |
| 2013 | 1.43 Billion EUR | -9.22% |
| 2012 | 1.57 Billion EUR | 0.02% |
| 2011 | 1.57 Billion EUR | 0.87% |
| 2010 | 1.56 Billion EUR | 8.88% |
| 2009 | 1.43 Billion EUR | 14.7% |
| 2008 | 1.25 Billion EUR | -3.97% |
| 2007 | 1.3 Billion EUR | 1.15% |
| 2006 | 1.28 Billion EUR | 27.2% |
| 2005 | 1.01 Billion EUR | 66.15% |
| 2004 | 609.69 Million EUR | 1.48% |
| 2003 | 600.77 Million EUR | 10.55% |
| 2002 | 543.43 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 519.82 Million EUR | 4.15% |
| 2024 Q2 | 518.1 Million EUR | -0.33% |
| 2023 Q1 | 472.57 Million EUR | 4.2% |
| 2023 Q2 | 482.16 Million EUR | 2.03% |
| 2023 FY | 499.09 Million EUR | 10.05% |
| 2023 Q3 | 492.93 Million EUR | 2.23% |
| 2023 Q4 | 499.09 Million EUR | 1.25% |
| 2022 Q2 | 453.85 Million EUR | 1.8% |
| 2022 FY | 453.51 Million EUR | 2.88% |
| 2022 Q3 | 459.21 Million EUR | 1.18% |
| 2022 Q4 | 453.51 Million EUR | -1.24% |
| 2022 Q1 | 445.81 Million EUR | 1.13% |
| 2021 Q4 | 440.81 Million EUR | -2.02% |
| 2021 Q1 | 452.65 Million EUR | 3.0% |
| 2021 FY | 440.81 Million EUR | 0.31% |
| 2021 Q3 | 449.91 Million EUR | 1.03% |
| 2021 Q2 | 445.32 Million EUR | -1.62% |
| 2020 FY | 439.44 Million EUR | -1.49% |
| 2020 Q1 | 447.89 Million EUR | 0.4% |
| 2020 Q2 | 448.85 Million EUR | 0.21% |
| 2020 Q3 | 445.14 Million EUR | -0.83% |
| 2020 Q4 | 439.44 Million EUR | -1.28% |
| 2019 Q2 | 417.54 Million EUR | -4.2% |
| 2019 FY | 446.11 Million EUR | 3.73% |
| 2019 Q1 | 435.87 Million EUR | 1.35% |
| 2019 Q4 | 446.11 Million EUR | -4.37% |
| 2019 Q3 | 466.48 Million EUR | 11.72% |
| 2018 Q4 | 430.06 Million EUR | 31.84% |
| 2018 Q1 | 368.34 Million EUR | 6.41% |
| 2018 FY | 430.06 Million EUR | 24.25% |
| 2018 Q2 | 365.56 Million EUR | -0.75% |
| 2018 Q3 | 326.19 Million EUR | -10.77% |
| 2017 Q3 | 340.54 Million EUR | -1.4% |
| 2017 FY | 346.14 Million EUR | 0.96% |
| 2017 Q4 | 346.14 Million EUR | 1.64% |
| 2017 Q2 | 345.39 Million EUR | -0.98% |
| 2017 Q1 | 348.81 Million EUR | 1.74% |
| 2016 Q3 | 355.37 Million EUR | 4.1% |
| 2016 Q2 | 341.37 Million EUR | -4.27% |
| 2016 Q4 | 342.86 Million EUR | -3.52% |
| 2016 FY | 342.86 Million EUR | -34.79% |
| 2016 Q1 | 356.61 Million EUR | -32.17% |
| 2015 FY | 525.77 Million EUR | -5.33% |
| 2015 Q4 | 525.77 Million EUR | -25.14% |
| 2015 Q3 | 702.38 Million EUR | 35.92% |
| 2015 Q2 | 516.74 Million EUR | -3.45% |
| 2015 Q1 | 535.2 Million EUR | -3.63% |
| 2014 FY | 555.38 Million EUR | -61.2% |
| 2014 Q2 | 599.72 Million EUR | -30.04% |
| 2014 Q1 | 857.29 Million EUR | -40.11% |
| 2014 Q3 | 2.2 Billion EUR | 267.46% |
| 2014 Q4 | 555.38 Million EUR | -74.8% |
| 2013 Q1 | 1.55 Billion EUR | -1.69% |
| 2013 FY | 1.43 Billion EUR | -9.22% |
| 2013 Q4 | 1.43 Billion EUR | 3.15% |
| 2013 Q3 | 1.38 Billion EUR | -2.99% |
| 2013 Q2 | 1.43 Billion EUR | -7.73% |
| 2012 Q1 | 1.53 Billion EUR | -2.35% |
| 2012 Q2 | 1.76 Billion EUR | 14.66% |
| 2012 Q3 | 1.55 Billion EUR | -11.78% |
| 2012 Q4 | 1.57 Billion EUR | 1.27% |
| 2012 FY | 1.57 Billion EUR | 0.02% |
| 2011 Q1 | 1.54 Billion EUR | -1.46% |
| 2011 FY | 1.57 Billion EUR | 0.87% |
| 2011 Q2 | 1.53 Billion EUR | -0.1% |
| 2011 Q3 | 1.47 Billion EUR | -3.95% |
| 2011 Q4 | 1.57 Billion EUR | 6.67% |
| 2010 Q1 | 1.49 Billion EUR | 3.9% |
| 2010 FY | 1.56 Billion EUR | 8.88% |
| 2010 Q4 | 1.56 Billion EUR | 3.14% |
| 2010 Q3 | 1.51 Billion EUR | 0.45% |
| 2010 Q2 | 1.5 Billion EUR | 1.15% |
| 2009 FY | 1.43 Billion EUR | 14.7% |
| 2009 Q4 | 1.43 Billion EUR | 0.0% |
| 2008 FY | 1.25 Billion EUR | -3.97% |
| 2007 FY | 1.3 Billion EUR | 1.15% |
| 2006 FY | 1.28 Billion EUR | 27.2% |
| 2005 FY | 1.01 Billion EUR | 66.15% |
| 2004 FY | 609.69 Million EUR | 1.48% |
| 2003 FY | 600.77 Million EUR | 10.55% |
| 2002 FY | 543.43 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| The Amacore Group, Inc. | 24.7 Million USD | -1919.851% |
| Arem Pacific Corporation | 304.9 Thousand USD | -163590.748% |
| Assisted 4 Living, Inc. | 184.16 Thousand USD | -270902.948% |
| BioCorRx Inc. | 10.34 Million USD | -4726.208% |
| Bionik Laboratories Corp. | 5 Million USD | -9876.543% |
| Banyan Corp. | 4.51 Million USD | -10945.818% |
| Clearday, Inc. | 65.13 Million USD | -666.286% |
| Dental Patient Care America, Inc. | 1.8 Million USD | -27595.34% |
| Quantum Medical Transport, Inc. | 1504.02 USD | -33184166.167% |
| Empower Clinics Inc. | 9.18 Million USD | -5333.4% |
| First Choice Healthcare Solutions, Inc. | 31.65 Million USD | -1476.765% |
| Selectis Health, Inc. | 43.63 Million USD | -1043.795% |
| Ethema Health Corporation | 17.71 Million USD | -2716.667% |
| HealthLynked Corp. | 3.47 Million USD | -14260.838% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 14.47 Million USD | -3348.059% |
| JRSIS Health Care Corporation | 2.3 Million USD | -21551.179% |
| Comjoyful International Company | 6.32 Million USD | -7789.512% |
| Medical Facilities Corporation | 235.37 Million USD | -112.047% |
| MedSmart Group Inc. | 927.53 Thousand USD | -53709.307% |
| North America Frac Sand, Inc. | 936.85 Thousand USD | -53174.057% |
| Nova Leap Health Corp. | 2.69 Million USD | -18392.261% |
| Nexteligent Holdings, Inc. | 2.88 Million USD | -17216.966% |
| PAO Group, Inc. | 1.04 Million USD | -47589.291% |
| Primemd Inc. | 7.98 Million USD | -6147.555% |
| Raffles Medical Group Ltd | 367.04 Million USD | -35.976% |
| Ryman Healthcare Limited | 5.17 Billion USD | 90.365% |
| Stem Cell Authority, Ltd. | 80.52 Thousand USD | -619705.029% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 3.91 Million USD | -12645.686% |
| Mycotopia Therapies, Inc. | 4.24 Million USD | -11649.777% |
| U.S. NeuroSurgical Holdings, Inc. | 676 Thousand USD | -73731.065% |
| Veltex Corporation | 2.87 Million USD | -17246.427% |
| World Financial Holding Group | 132.5 Thousand USD | -376563.522% |
| Xcelerate Inc. | 2.07 Million USD | -23946.31% |